baby calendar Inc.
Fiscal Year Ending December 2026 Q3 Financial Summary [Japanese GAAP] (Non-consolidated)
For the nine months ended Q3 FY2026, revenue was 1,431 million yen (Year-over-Year 2.5% increase), operating income was 109 million yen (YoY -22.8%), and quarterly net income was 59 million yen (YoY -24.9%), showing a slowdown. Meanwhile, revenue to medical corporations was 305 million yen (YoY 81.3% increase) with significant growth. Full-year FY2026 forecasts are unchanged; note that consolidated reporting will commence from FY2026 due to the acquisition of Orange Page.
Key Figures
- Revenue: 1,431,929 thousand yen (Year-over-Year 2.5% increase)
- Operating Income: 109,629 thousand yen (Year-over-Year -22.8% decrease)
- Revenue to Medical Corporations: 305,090 thousand yen (Year-over-Year 81.3% increase)
AI要約
Overview of Results
While cumulative revenue for the third quarter increased, operating income, ordinary income and net income trailed the prior year. The media business maintained a recovery trend in advertising revenue but was affected by the suspension of monetization on certain channels, resulting in a decrease versus the prior year. The business for medical corporations showed substantial growth in both revenue and segment profit driven by expanded new implementations. Full-year forecasts for FY2026 remain unchanged, and consolidated reporting is scheduled to begin from FY2026 due to the acquisition of Orange Page as a wholly owned subsidiary.
Outlook and Key Points
The transition to consolidated financial statements due to the acquisition of Orange Page is scheduled to begin in FY2026, and consolidated forecasts are currently under review. Although quarterly advertising revenue recovery continues, the financial summary notes uncertain elements that could affect forecasts and should be monitored as potential volatility factors. The medical corporation business is performing steadily and should be watched as a medium- to long-term growth driver.
Revenue Trend
Operating Income Trend
Segment Revenue Breakdown
Guidance vs Actual Comparison
baby calendar Inc.
Company overview · Stock price · Financial data · All IR
